Delivery Order SPE2DB20D7066-SPE2DB24FC2NR
Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $101K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $76,416.04 firm fixed price contract is for the supply of GARDASIL 9 syringes, a vaccine product, with an ultimate completion date of August 21, 2024. The contract is not set aside for any small business designation. AmerisourceBergen is one of the largest pharmaceutical distributors in the U.S. and has numerous indefinite delivery contracts (IDCs) with federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,305.05 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, valued at $23,928.34 and has a completion date of July 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with the DLA and other...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,074.64 firm-fixed-price contract is for the supply of 4565907464 GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of September 24, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.47, is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a period of performance through March 26, 2025 and is a firm-fixed-price contract. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,683.96 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of March 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,123.92 firm-fixed-price contract is for the delivery of 4565430340 units of the GARDASIL 9 vaccine syringe (0.5 ML). The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a comprehensive range of medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,932.32 firm fixed-price contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a period of performance ending on November 19, 2024. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $15,351.82 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract has a completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies to...